TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “ Company” or “PharmaTher”) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (“Common Shares”) and warrants to purchase common shares (“Warrants”) for gross…
